Crohn’s & Colitis Congress™
Tweet
Sessions
Speakers
Exhibitors
Floor Plan
Buzz
Search
Sessions
(42)
View/Sort by
Tracks
|
Day
Details
1 - EFFECTIVENESS OF ORAL IRON SUPPLEMENTATION IN THE TREATMENT OF ANEMIA ASSOCIATED WITH PEDIATRIC ULCERATIVE COLITIS FLARE
(
Room
Bristlecone 4
)
18 Jan 18
2:30 PM
-
2:40 PM
Cutting-Edge Pediatric IBD ($$)
(
Room
Bristlecone 4
)
18 Jan 18
1:00 PM
-
5:00 PM
8 - TELEMEDICINE FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE (TELE-IBD) DECREASES INFLAMMATORY BOWEL DISEASE (IBD)-RELATED HOSPITALIZATIONS
(
Room
Pinyon 3
)
18 Jan 18
3:20 PM
-
3:35 PM
The Lloyd Mayer, MD, Young IBD Investigators Clinical, Basic and Translational Research Workshop
(
Room
Pinyon 3
)
18 Jan 18
1:00 PM
-
5:00 PM
9 - INFECTIOUS AND THROMBOTIC RISKS OF PARENTERAL NUTRITION IN HOSPITALIZED PEDIATRIC IBD PATIENTS
(
Room
Pinyon 3
)
18 Jan 18
3:35 PM
-
3:50 PM
Poster Reception
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
13 - REFINED POPULATION PHARMACOKINETIC MODEL FOR INFLIXIMAB PRECISION DOSING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
(
Room
Pinyon 4/5
)
19 Jan 18
2:20 PM
-
2:30 PM
14 - POST-HOC ANALYSIS OF TOFACITINIB CROHN’S DISEASE PHASE 2 INDUCTION EFFICACY IN SUBGROUPS WITH BASELINE ENDOSCOPIC OR BIOMARKER EVIDENCE OF INFLAMMATION
(
Room
Pinyon 4/5
)
19 Jan 18
2:50 PM
-
3:00 PM
P132 - A DEEPER LOOK INTO MEDICAL FOODS: WHERE IS THE BEST PATIENT-CENTERED INFORMATION?
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P133 - AN ANALYSIS OF SURGICAL OUTCOMES IN IBD PATIENTS TREATED WITH AND WITHOUT BIOLOGIC THERAPY
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P134 - BEYOND THE “BIG PICTURE”: CAN MICRONUTRIENTS IMPACT SURGICAL OUTCOMES IN IBD?
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P135 - BIOLOGICAL EVIDENCE OF TOFACITINIB EFFICACY IN CROHN'S DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P136 - CERTOLIZUMAB PEGOL IS EFFECTIVE IN THE MAINTENANCE OF RESPONSE IN MODERATE-SEVERE ULCERATIVE COLITIS: AN OPEN-LABEL MAINTENANCE STUDY
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P137 - CLINICAL FACTORS RELATED TO LOW BONE MINERAL DENSITY IN NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P138 - COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB VS. INFLIXIMAB INDUCTION THERAPY IN ULCERATIVE COLITIS: EXPERIENCE OF A REAL-WORLD COHORT AT A TERTIARY IBD CENTER
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P139 - CORRELATION OF CLINICAL REMISSION WITH MUCOSAL HEALING IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P140 - CURRENT STATUS OF HOME INFUSIONS FOR INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P141 - DEVELOPMENT OF A SELF-SCREENING TOOL FOR PERIANAL DISEASE IN PATIENTS WITH CROHN’S DISEASE: A PILOT STUDY
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P142 - DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL TO EVALUATE INDUCTION OF CLINICAL RESPONSE IN PATIENTS WITH MODERATE-SEVERE CROHN’S DISEASE TREATED WITH RIFAXIMIN
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P143 - EARLY VERSUS DELAYED INITIATION OF POSTOPERATIVE PHARMACOLOGICAL PROPHYLAXIS TO PREVENT SURGICAL RECURRENCE AFTER INTESTINAL RESECTION IN PATIENTS WITH CROHN’S DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P144 - ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF THERAPY TO ADALIMUMAB, INFIXIMAB OR OTHER ANTI-TNF COMPARED WITH SWITCHING FROM ANTI-TNF THERAPY TO VEDOLIZUMAB
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P145 - GOLIMUMAB DRUG LEVELS DURING MAINTENANCE THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P146 - IMPACT OF CT-DERIVED BONE STRENGTH ASSESSMENT IN INFLAMMATORY BOWEL DISEASE PATIENTS UNDERGOING CT ENTEROGRAPHY IN CLINICAL PRACTICE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P147 - IMPLEMENTATION OF A NEW ORAL CONTRAST AGENT FOR CT AND MR ENTEROGRAPHY IN PEDIATRIC IBD CLINICAL PRACTICE: IMPACT ON TOLERABILITY, DISTENSION, IMAGE QUALITY AND DIAGNOSTIC CONFIDENCE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P148 - LACK OF INFLUENCE OF ELDERLY AGE AND GENDER ON THE SAFETY PROFILE OF BUDESONIDE EXTENDED-RELEASE TABLETS FOR ULCERATIVE COLITIS: A POOLED ANALYSIS OF TWO RANDOMIZED, DOUBLE-BLIND, PHASE 3 TRIALS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P149 - LONG-TERM SAFETY AND EFFICACY OF FECAL MICROBIOTA TRANSPLANTATION IN THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION IN PATIENTS WITH AND WITHOUT INFLAMMATORY BOWEL DISEASE: A TERTIARY CARE CENTER'S EXPERIENCE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P150 - MICROBIOME RISK SCORE (MRS) IN THE DIAGNOSIS AND CLASSIFICATION OF INFLAMMATORY BOWEL DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P151 - NONIMMUNITY AGAINST HEPATITIS B VIRUS IN PATIENTS WITH NEWLY DIAGNOSED INFLAMMATORY BOWEL DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P152 - PATIENT EXPERIENCES WITH COLORECTAL CANCER SURVEILLANCE (CRC) IN INFLAMMATORY BOWEL DISEASE (IBD): A QUALITATIVE STUDY
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P153 - PATIENT, PARENT, AND PROVIDER PERCEPTIONS OF BARRIERS TO PEDIATRIC INFLAMMATORY BOWEL DISEASE CARE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P154 - PRIMARY NON-RESPONSE TO TUMOR NECROSIS FACTOR ANTAGONISTS IS ASSOCIATED WITH INFERIOR RESPONSE TO SECOND-LINE BIOLOGICS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A SYSTEMATIC REVIEW AND META-ANALYSIS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P155 - REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P156 - REDUCTION IN THE PREVALENCE OF ANEMIA AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE AFTER IMPLEMENTATION OF THE ANEMIA CARE PATHWAY
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P157 - REPLICATING THE PATIENT’S APPROACH: A SEARCH FOR MEDICAL FOODS IN IBD
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P158 - RISK FACTORS FOR NON-ADHERENCE TO BIOLOGIC THERAPIES IN INFLAMMATORY BOWEL DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P159 - SEARCHING FOR MORE: THE NEED FOR HIGH-QUALITY INFORMATION AND PATIENT-CENTERED LANGUAGE IN ONLINE RESOURCES FOR MEDICAL FOODS IN IBD
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P160 - SERUM ALBUMIN WEEK 6/WEEK 0 RATIO AFTER anti-TNF BEST PREDICTS BOTH SHORT- AND LONG-TERM CLINICAL OUTCOMES IN ANTI-TNF-NAÏVE ULCERATIVE COLITIS PATIENTS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P161 - SUSTAINABLE IMPROVEMENTS IN URGENT CARE ACCESS AND OUTCOMES FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE THROUGH IMPLEMENTATION OF AN URGENT ACCESS TOOLKIT.
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P162 - THE GENE EXPRESSION LANDSCAPE OF COBBLESTONE LESIONS IN CROHN’S DISEASE-LIKE ILEITIS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P163 - TRANSITION TO BIOLOGIC HOME INFUSIONS IN IBD PATIENTS IS ASSOCIATED WITH HIGH DROP OUT WITHIN ONE YEAR
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P164 - USING EXOME SEQUENCING TO EXPAND THE GENETIC ARCHITECTURE OF INFLAMMATORY BOWEL DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P165 - UTILIZATION OF REACTIVE DRUG LEVEL MONITORING IN INFLAMMATORY BOWEL DISEASE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P166 - VEDOLIZUMAB MARKET ACCESS ANALYSIS OF HEALTH INSURANCE IBD POLICIES
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P167 - VEDOLIZUMAB TROUGH LEVELS AND ANTIBODIES IN INFLAMMATORY BOWEL DISEASE: UPDATED INITIAL EXPERIENCE
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
P168 - WHERE WILL FECAL MICROBIOTA TRANSPLANTATION FIT IN THE TREATMENT ALGORITHMS FOR CROHN’S DISEASE AND ULCERATIVE COLITIS: A SYNTHESIS OF COMPLETED, ONGOING AND FUTURE TRIALS
(
Room
Poster Hall
)
19 Jan 18
5:30 PM
-
7:00 PM
Home
Sessions
Speakers
Exhibitors
Floor Plan
Tweet
Login
|
Back to top
ChirpE